Global Tissue Banking Market Size To Reach $6.2 Billion By 2035

Global tissue banking market is projected to grow from $3.1 billion in 2025 and is projected to reach $6.2 billion by 2035, growing at a CAGR of 7.2% during the forecast period 2026-2035. The global tissue banking market is shaped by the increasing need for reliable preservation of biological materials used in both clinical and research settings. A key driver is the growing demand for transplantable tissues and the limited window available for preserving biological samples, which has led to greater reliance on advanced storage techniques. At the same time, the rise in chronic diseases and surgical procedures has increased the requirement for stored tissues across multiple therapeutic areas. Continuous progress in cryopreservation methods, including improved freezing protocols and preservation solutions, is enhancing sample viability and extending storage duration. Institutions are also placing stronger emphasis on maintaining sample quality and traceability, which is influencing the procurement of specialized equipment and consumables. In addition, the expansion of biobanking infrastructure is supporting wider collection and storage of disease-specific samples. These combined factors are contributing to steady and sustained market development.

Browse the full report description of “Tissue Banking Market Size, Share & Trends Analysis Report, By Products (Equipment and Consumables & Media) By Applications (Medical Research, Therapeutics, and Others), Forecast Period (2026-2035)” at https://www.omrglobal.com/industry-reports/tissue-banking-market-size

Another important trend is the growing integration of tissue banking with regenerative medicine and advanced research applications. Increasing focus on stem cell research and tissue engineering is creating consistent demand for well-preserved biological materials used in experimental and clinical workflows. There is also a noticeable shift toward automation in storage and handling processes, which improves operational efficiency and reduces the risk of contamination. The adoption of standardized protocols and regulatory oversight is further encouraging the use of validated preservation systems across laboratories and healthcare institutions. Moreover, collaboration between research organizations and healthcare providers is expanding access to high-quality tissue samples for translational studies. As personalized medicine continues to evolve, the need for accurately preserved and well-characterized tissues is expected to remain a central factor influencing the market.

Competitive Landscape of the Tissue Banking Market

The key players in the tissue banking market are Thermo Fisher Scientific Inc., Merck KGaA, Avantor Inc., Sartorius AG, and Agilent Technologies Inc., among others. Market participants in this space operate through diversified portfolios that include preservation media, cryogenic storage systems, and specialized laboratory equipment. Their focus remains on improving product reliability, ensuring compliance with regulatory standards, and supporting consistent sample integrity across clinical and research applications. Ongoing efforts are directed toward enhancing technological capabilities and expanding global distribution reach. These strategies enable suppliers to address evolving requirements in tissue preservation and handling workflows.

• In March 2025, AlloSource Inc reported continued expansion of its AceConnex pre-sutured fascia device derived from preserved human tissue, reflecting ongoing development of tissue-based products linked to banking and preservation workflows.

• In February 2024, Azenta Inc. launched the BioArc Ultra automated ultracold storage system, designed for high-density sample management in biorepositories, offering energy-efficient cooling and automation features to improve large-scale tissue and biospecimen storage operations.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Products
  • By Applications
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape - Thermo Fisher Scientific Inc., Merck KGaA, Avantor Inc., Sartorius AG, and Agilent Technologies Inc., among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Tissue Banking Market Report Segment

By Products

• Equipment
• Consumables & Media

By Applications

• Medical Research
• Therapeutics
• Others

Global Tissue Banking Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/tissue-banking-market-size